all report title image

CDMO INJECTABLE DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

CDMO Injectable Drugs Market, By Product Type (Small Molecule Injectables and Large Molecule Injectables), By Drug Class (Antidiabetics, Cardiovascular Drugs, Anti-infectives, Analgesics and Anesthetics, Oncology Drugs, Vaccines, CNS Drugs, Hormonal Drugs, and Others), By Application (Oncology, Diabetes, Autoimmune Diseases, Hematological Disorders, Cardiovascular Diseases, Infectious Diseases, Neurological Disorders, Pain Management, Rare Diseases, and Others), By Route of Administration (Intramuscular (IM), Intravenous (IV), Subcutaneous (SC), and Others), By Scale of Operations (Preclinical Development, Clinical Development (Phases I–III), and Commercial / Large-Scale Manufacturing), By End User (Biopharmaceutical Companies, Generic Drug Manufacturers, Contract Research Organizations (CROs), and Academic and Research Institutes), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

  • Published In: 16 Apr, 2026
  • Code: CMI9438
  • Page number: 168
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026 - 2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global CDMO Injectable Drugs Market, By Product Type
      • Global CDMO Injectable Drugs Market, By Drug Class
      • Global CDMO Injectable Drugs Market, By Application
      • Global CDMO Injectable Drugs Market, By Route of Administration
      • Global CDMO Injectable Drugs Market, By Scale of Operations
      • Global CDMO Injectable Drugs Market, By End User
      • Global CDMO Injectable Drugs Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Regulatory Scenario
    • Key Developments
    • Industry Trends
  4. Global CDMO Injectable Drugs Market, By Product Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Small Molecule Injectables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Large Molecule Injectables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  5. Global CDMO Injectable Drugs Market, By Drug Class, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Antidiabetics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Cardiovascular Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Anti-infectives
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Analgesics and Anesthetics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Oncology Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • CNS Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Hormonal Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  6. Global CDMO Injectable Drugs Market, By Application, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Autoimmune Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Hematological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Cardiovascular Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Neurological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Pain Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Rare Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  7. Global CDMO Injectable Drugs Market, By Route of Administration, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Intramuscular (IM)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Intravenous (IV)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Subcutaneous (SC)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  8. Global CDMO Injectable Drugs Market, By Scale of Operations, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Preclinical Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Clinical Development (Phases I–III)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Commercial / Large-Scale Manufacturing
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  9. Global CDMO Injectable Drugs Market, By End User, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Biopharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Generic Drug Manufacturers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Contract Research Organizations (CROs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Academic and Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  10. Global CDMO Injectable Drugs Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Scale of Operations, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  11. Competitive Landscape

    • Lonza Group
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Thermo Fisher Scientific
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Catalent, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Samsung Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • WuXi Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • FUJIFILM Diosynth Biotechnologies
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Boehringer Ingelheim
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Recipharm AB
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Siegfried Holding AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • AGC Biologics
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  12. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  13. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on ‘CDMO Injectable Drugs Market' - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.